Incomplete endoscopic resection of colorectal polyps: a prospective quality assurance study.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 23 9 2020
medline: 27 4 2021
entrez: 22 9 2020
Statut: ppublish

Résumé

 Endoscopic screening with polypectomy has been shown to reduce colorectal cancer incidence in randomized trials. Incomplete polyp removal and subsequent development of post-colonoscopy cancers may attenuate the effect of screening. This study aimed to quantify the extent of incomplete polyp removal.  We included patients aged 50-75 years with nonpedunculated polyps ≥ 5 mm removed during colonoscopy at four hospitals in Norway. To evaluate completeness of polyp removal, biopsies from the resection margins were obtained after polypectomy. Logistic regression models were fitted to identify factors explaining incomplete resection.  246 patients with 339 polyps underwent polypectomy between January 2015 and June 2017. A total of 12 polyps were excluded due to biopsy electrocautery damage, and 327 polyps in 246 patients (mean age 67 years [range 42-83]; 52 % male) were included in the analysis. Overall, 54 polyps (15.9 %) in 54 patients were incompletely resected. Histological diagnosis of the polyp (sessile serrated lesions vs. adenoma, odds ratio [OR] 10.9, 95 % confidence interval [CI] 3.9-30.1) and polyp location (proximal vs. distal colon, OR 2.8, 95 %CI 1.0-7.7) were independent risk factors for incomplete removal of polyps 5-19 mm. Board-certified endoscopists were not associated with lower rates of incomplete resection compared with trainees (14.0 % vs. 14.2 %), OR 1.0 (95 %CI 0.5-2.1). Incomplete polyp resection was frequent after polypectomy in routine clinical practice. Serrated histology and proximal location were independent risk factors for incomplete resection. The performance of board-certified gastroenterologists was not superior to that of trainees.

Sections du résumé

BACKGROUND BACKGROUND
 Endoscopic screening with polypectomy has been shown to reduce colorectal cancer incidence in randomized trials. Incomplete polyp removal and subsequent development of post-colonoscopy cancers may attenuate the effect of screening. This study aimed to quantify the extent of incomplete polyp removal.
METHODS METHODS
 We included patients aged 50-75 years with nonpedunculated polyps ≥ 5 mm removed during colonoscopy at four hospitals in Norway. To evaluate completeness of polyp removal, biopsies from the resection margins were obtained after polypectomy. Logistic regression models were fitted to identify factors explaining incomplete resection.
RESULTS RESULTS
 246 patients with 339 polyps underwent polypectomy between January 2015 and June 2017. A total of 12 polyps were excluded due to biopsy electrocautery damage, and 327 polyps in 246 patients (mean age 67 years [range 42-83]; 52 % male) were included in the analysis. Overall, 54 polyps (15.9 %) in 54 patients were incompletely resected. Histological diagnosis of the polyp (sessile serrated lesions vs. adenoma, odds ratio [OR] 10.9, 95 % confidence interval [CI] 3.9-30.1) and polyp location (proximal vs. distal colon, OR 2.8, 95 %CI 1.0-7.7) were independent risk factors for incomplete removal of polyps 5-19 mm. Board-certified endoscopists were not associated with lower rates of incomplete resection compared with trainees (14.0 % vs. 14.2 %), OR 1.0 (95 %CI 0.5-2.1).
CONCLUSION CONCLUSIONS
Incomplete polyp resection was frequent after polypectomy in routine clinical practice. Serrated histology and proximal location were independent risk factors for incomplete resection. The performance of board-certified gastroenterologists was not superior to that of trainees.

Identifiants

pubmed: 32961579
doi: 10.1055/a-1243-0379
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

383-391

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Auteurs

Ina B Pedersen (IB)

Department of Medicine, Sorlandet Hospital Kristiansand, Kristiansand, Norway.
Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.

Michael Bretthauer (M)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.

Mette Kalager (M)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.

Magnus Løberg (M)

Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.

Geir Hoff (G)

Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Department of Medicine, Telemark Hospital Skien, Skien, Norway.

Senaria Matapour (S)

Department of Medicine, Vestre Viken Hospital Trust, Gjettum, Norway.

Silje Hugin (S)

Department of Medicine, Vestre Viken Hospital Trust, Gjettum, Norway.

Svein O Frigstad (SO)

Department of Medicine, Vestre Viken Hospital Trust, Gjettum, Norway.

Birgitte Seip (B)

Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.

Britta A Kleist (BA)

Department of Pathology, Sorlandet Hospital Kristiansand, Norway.

Leif Løvdal (L)

Department of Pathology, Sorlandet Hospital Kristiansand, Norway.

Edoardo Botteri (E)

Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.

Øyvind Holme (Ø)

Department of Medicine, Sorlandet Hospital Kristiansand, Kristiansand, Norway.
Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH